Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Colitis, Ulcerative × Lymphoid × Clear all

Status

Completed 5 Terminated 3 Unknown 1 Recruiting 1 Enrolling by invitation 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 2 Lymphoid 1

Conditions

Lymphoma 146 Lymphoma, Non-Hodgkin 130 Leukemia, Lymphocytic, Chronic, B-Cell 125 Precursor Cell Lymphoblastic Leukemia-Lymphoma 124 Lymphoma, Large B-Cell, Diffuse 108 Lymphoma, Follicular 96 Lymphoma, B-Cell 65 Hodgkin Disease 63 Lymphoma, Mantle-Cell 62 Leukemia 56 Multiple Myeloma 54 Recurrence 46 Leukemia, Myeloid, Acute 44 Burkitt Lymphoma 43 Lymphoma, B-Cell, Marginal Zone 42 Myelodysplastic Syndromes 41 Neoplasms 40 Hematologic Neoplasms 31 Waldenstrom Macroglobulinemia 25 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 19 Lymphoma, T-Cell 17 Lymphoma, T-Cell, Peripheral 16 Lymphoma, T-Cell, Cutaneous 16 Leukemia, B-Cell 15 Myeloproliferative Disorders 14 Mycosis Fungoides 14 Lymphoma, Large-Cell, Anaplastic 14 Sarcoma 13 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13 Leukemia, Biphenotypic, Acute 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02808780 2026-03-13

OPAL

Janssen Biotech, Inc.

Active not recruiting

Colitis, Ulcerative, Lymphoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡